Neuvasq Biotechnologies
PrivateLast Round
Series A
Jun 22, 2021
Total Funding Raised
$23.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuvasq Biotechnologies is a biotechnology company that develops multispecific antibody-based therapies to restore and protect the integrity of the blood-brain and blood-retina barriers for the treatment of neurological and ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuvasq Biotechnologies Comparables
Compare Neuvasq Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 79% | |
| Lys Therapeutics | 78% | |
| Surrozen | 74% | |
Neuvasq Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 22, 2021 |
Neuvasq Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Newton Biocapital | Series A |
| Wallonie Entreprendre | Series A |
| ORSA | Series A |
| Sambrinvest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 79% MoM.
- Apr 16, 2026
Monthly visitors increased 2700% MoM.
Neuvasq Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuvasq Biotechnologies's valuation, stock price, and market status.